Unexpected higher blood loss associated with higher dose ε-aminocaproic acid in pediatric scoliosis surgery.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 30199414.
- Also identified by DOI 10.1097/BPB.0000000000000545.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to determine if a higher dosing of ε-aminocaproic acid (EACA) is associated with less perioperative blood loss than a lower dose. A total of 74 patients having scoliosis surgery were analyzed. Of the 74 patients, 36 patients received EACA (10 mg/kg/h) and 38 patients received EACA (33 mg/kg/h). After controlling for key variables, an infusion of 33 mg/kg/h of EACA was associated with an increase in intraoperative blood loss of 8.1 ml/kg compared with an infusion of 10 mg/kg/h of EACA. A 33 mg/kg/h intraoperative infusion is associated with higher intraoperative blood loss than an infusion at 10 mg/kg/h.
Medical subject headings
- Aminocaproic Acid
- Antifibrinolytic Agents
- Blood Loss, Surgical
- Scoliosis